This inventor holds 1 USPTO granted patent. Top assignees: Shanghaitech University, Xuzhou Medical University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xudong Cao: Innovator in Pharmaceutical Chemistry
Introduction
Xudong Cao is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzoazepine compounds. His research focuses on the development of novel compounds that have potential therapeutic applications.
Latest Patents
Xudong Cao holds 1 patent for a benzoazepine compound, which includes a pharmaceutically acceptable salt thereof. This patent describes a pharmaceutical composition that comprises the compound and its salts. The invention is aimed at the prevention or treatment of diseases related to the arginine vasopressin V1a receptor, V1b receptor, V2 receptor, sympathetic nervous system, or the renin-angiotensin-aldosterone system. The compound is represented by a specific formula, with defined substituents that enhance its efficacy in treating arginine vasopressin-related diseases.
Career Highlights
Throughout his career, Xudong Cao has been associated with prestigious institutions such as Xuzhou Medical University and ShanghaiTech University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Xudong Cao has collaborated with notable colleagues, including Dong Guo and Wenzhong Yan. These collaborations have enriched his research and expanded the impact of his innovations in the field.
Conclusion
Xudong Cao's contributions to pharmaceutical chemistry, particularly through his patented benzoazepine compound, highlight his role as an innovator in the industry. His work continues to pave the way for advancements in the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile